Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.27

+6.0%

Jan 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2606)	9/25/2009 1:36:26 PM
From: Jibacoa	of 3722

ISRG is going over the resistance at the $250 level, without closing its July 23 UG and in spite of its poor report on the 1stQ, but with the help of better report on the 2ndQ. <g> The stock is up 5.05% with volume > its ADV. bigcharts.marketwatch.com ISRG has NSLTD, has +CF around $5.85 and the EE for 2009 and 2010 are $5.35 and $6.60 vs. the $5.12 in 2008 The short ratio had increased about 8% and was around 6x its ADV The ACTAY is $203, but it seems that if the general market improves, and with some good news, the stock could get to the $270 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next